Whittier Trust’s Haemonetics HAE Stock Holding History

Whittier Trust’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60K	Hold	800	–	–	﹤0.01%	847
2026 Q1	$46.8K	Hold	800	–	–	﹤0.01%	850
2025 Q4	$66.2K	Hold	800	–	–	﹤0.01%	813
2025 Q3	$40.4K	Hold	800	–	–	﹤0.01%	893
2025 Q2	$59.7K	Hold	800	–	–	﹤0.01%	902
2025 Q1	$50.8K	Hold	800	–	–	﹤0.01%	927
2024 Q4	$62.5K	Buy	+800	New	+$64.3K	﹤0.01%	898
2017 Q2	–	Sell	-115	Closed	-$5K	–	1282
2017 Q1	$5K	Buy	+115	New	+$4.49K	﹤0.01%	1137
2015 Q4	–	Sell	-125	Closed	-$4K	–	1201
2015 Q3	$4K	Hold	125	–	–	﹤0.01%	1053
2015 Q2	$5K	Sell	125 -178	-59%	-$7.5K	﹤0.01%	1083
2015 Q1	$14K	Buy	303 +178	+142%	+$7.44K	﹤0.01%	951
2014 Q4	$5K	Hold	125	–	–	﹤0.01%	948
2014 Q3	$4K	Hold	125	–	–	﹤0.01%	954
2014 Q2	$4K	Hold	125	–	–	﹤0.01%	956
2014 Q1	$4K	Hold	125	–	–	﹤0.01%	975
2013 Q4	$5K	Hold	125	–	–	﹤0.01%	963
2013 Q3	$5K	Sell	125 -20,264	-99%	-$850K	﹤0.01%	965
2013 Q2	$843K	Buy	+20,389	New	+$825K	0.05%	248

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Whittier Trust's HAE Position: Q2 2026 in Review

Whittier Trust held its Haemonetics (HAE) position steady in Q2 2026 at 800 shares worth $60K. The position accounts for ﹤0.01% of the portfolio, ranked #847.

Whittier Trust first reported a position in HAE in Q2 2013 and has held it in 18 quarters since. The position peaked at $843K in Q2 2013. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Whittier Trust held 800 shares of Haemonetics worth $60K as of Q2 2026.
Whittier Trust left its Haemonetics share count unchanged in Q2 2026.
Haemonetics made up ﹤0.01% of Whittier Trust's portfolio in Q2 2026, its #847 holding.
Whittier Trust first reported a position in Haemonetics in Q2 2013 and has held it in 18 quarters since.
Whittier Trust's Haemonetics position peaked at $843K in Q2 2013.
329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.